Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.04.2024 | Case report

Rituximab

Various toxicities

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Lan L, et al. Efficacy of Rituximab for Minimal Change Disease and Focal Segmental Glomerulosclerosis with Frequently Relapsing or Steroid-Dependent Nephrotic Syndrome in Adults: A Chinese Multicenter Retrospective Study. American Journal of Nephrology 55 : 25-36, No. 1, Feb 2024. Available from: URL: https://dx.doi.org/10.1159/000535010 Lan L, et al. Efficacy of Rituximab for Minimal Change Disease and Focal Segmental Glomerulosclerosis with Frequently Relapsing or Steroid-Dependent Nephrotic Syndrome in Adults: A Chinese Multicenter Retrospective Study. American Journal of Nephrology 55 : 25-36, No. 1, Feb 2024. Available from: URL: https://​dx.​doi.​org/​10.​1159/​000535010
Metadaten
Titel
Rituximab
Various toxicities
Publikationsdatum
01.04.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-57814-1

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Nivolumab

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Nitroglycerin

Case report

BBIBP-CorV